131 related articles for article (PubMed ID: 24519575)
1. The synthesis of (14)C-labeled, (13)CD2-labeled saxagliptin, and its (13)CD2-labeled 5-hydroxy metabolite.
Tran SB; Maxwell BD; Cao K; Bonacorsi SJ
J Labelled Comp Radiopharm; 2014 Mar; 57(3):136-40. PubMed ID: 24519575
[TBL] [Abstract][Full Text] [Related]
2. The syntheses of [
Maxwell BD
J Labelled Comp Radiopharm; 2017 Jun; 60(8):357-365. PubMed ID: 28273377
[TBL] [Abstract][Full Text] [Related]
3. The syntheses of [(14) C]BMS-823778 for use in a human ADME clinical study and of [(13) CD3 (13) CD2 ]BMT-094817, a stable-isotope labeled standard of a newly detected human metabolite.
Maxwell BD; Tran SB; Lago M; Li J; Bonacorsi SJ
J Labelled Comp Radiopharm; 2016 May; 59(6):255-9. PubMed ID: 27169762
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.
Dong J; Gong Y; Liu J; Chen X; Wen X; Sun H
Bioorg Med Chem; 2014 Feb; 22(4):1383-93. PubMed ID: 24457090
[TBL] [Abstract][Full Text] [Related]
5. A facile method for the synthesis of 2-(3-hydroxy-1-adamantyl)-2-oxoacetic acid and it's optimization.
Wang HF; Gan R; Zhou J; Liao Q; Wang TB; Zhong CL; Xiang YY; Lin HB; Hu XN
Pak J Pharm Sci; 2018 Jul; 31(4):1393-1397. PubMed ID: 30033425
[TBL] [Abstract][Full Text] [Related]
6. Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes.
Deacon CF; Holst JJ
Adv Ther; 2009 May; 26(5):488-99. PubMed ID: 19444391
[TBL] [Abstract][Full Text] [Related]
7. Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method validation and overcoming specific and non-specific binding at low concentrations.
Xu XS; Demers R; Gu H; Christopher LJ; Su H; Cojocaru L; Boulton DW; Kirby M; Stouffer B; Humphreys WG; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():77-86. PubMed ID: 22349123
[TBL] [Abstract][Full Text] [Related]
8. Syntheses of isotope-labeled SGLT2 inhibitor canagliflozin (JNJ-28431754).
Lin R; Hoerr DC; Weaner LE; Salter R
J Labelled Comp Radiopharm; 2017 Nov; 60(13):616-623. PubMed ID: 28833358
[TBL] [Abstract][Full Text] [Related]
9. Expeditious syntheses of stable and radioactive isotope-labeled anticonvulsant agent, JNJ-26990990, and its metabolites.
Lin R; Weaner LE; Hoerr DC; Salter R; Gong Y
J Labelled Comp Radiopharm; 2013 Jan; 56(1):22-6. PubMed ID: 24285137
[TBL] [Abstract][Full Text] [Related]
10. The syntheses of isotopically labelled CB-1 antagonists for the treatment of obesity.
Tran SB; Maxwell BD; Burrell R; Bonacorsi SJ
J Labelled Comp Radiopharm; 2016 Dec; 59(14):665-672. PubMed ID: 27624665
[TBL] [Abstract][Full Text] [Related]
11. Radiolabelling of steroids: the synthesis of 17α-[4-(14) C]trenbolone.
Hendry D; Knagg E; Smith NA; Woolley GT
J Labelled Comp Radiopharm; 2013; 56(9-10):455-60. PubMed ID: 24285520
[TBL] [Abstract][Full Text] [Related]
12. A novel no-carrier-added submicromolar scale radiosynthesis of [S-methyl-14C]-florfenicol.
Srinivas G; Prabhakar G; Unny VK; Sudhakar K; Mukkanti K; Choudary BM
J Labelled Comp Radiopharm; 2013 Jun; 56(8):382-4. PubMed ID: 24285477
[TBL] [Abstract][Full Text] [Related]
13. Syntheses of (3) H-labeled, (14) C-labeled, and (2) H4 -labeled SCH 444877, phosphodiesterase type 5 inhibitors.
Ren S; Hesk D; McNamara P; Koharski D; Hendershot S
J Labelled Comp Radiopharm; 2013; 56(9-10):480-4. PubMed ID: 24285525
[TBL] [Abstract][Full Text] [Related]
14. Carbon-14 labeling of K777•HCl, a therapeutic agent for Chagas disease.
Rhee SW; Bradford WW; Malerich JP; Tanga MJ
J Labelled Comp Radiopharm; 2013; 56(9-10):461-3. PubMed ID: 24285521
[TBL] [Abstract][Full Text] [Related]
15. Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation.
Metzler WJ; Yanchunas J; Weigelt C; Kish K; Klei HE; Xie D; Zhang Y; Corbett M; Tamura JK; He B; Hamann LG; Kirby MS; Marcinkeviciene J
Protein Sci; 2008 Feb; 17(2):240-50. PubMed ID: 18227430
[TBL] [Abstract][Full Text] [Related]
16. Syntheses of C-13 and C-14-labeled versions of the investigational proteasome inhibitor MLN9708.
Plesescu M; Elliott EL; Li Y; Prakash SR
J Labelled Comp Radiopharm; 2013; 56(9-10):464-70. PubMed ID: 24285522
[TBL] [Abstract][Full Text] [Related]
17. Straightforward preparation of labeled potassium cyanate by ozonation and application to the synthesis of [13C] or [14C]ureidocarboxylic acids.
Loreau O; Marlière P
J Labelled Comp Radiopharm; 2013 Jun; 56(7):347-50. PubMed ID: 24285437
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of the derivatives of 6-amino-uracil labelled with
Elbert T; Hezký P; Jansa P
J Labelled Comp Radiopharm; 2016 Dec; 59(14):615-618. PubMed ID: 27197875
[TBL] [Abstract][Full Text] [Related]
19. A short expedient synthesis of [(14)C]Ticlopidine.
Hickey MJ; Kingston LP; Allen PH; Johnson T; Wilkinson DJ
J Labelled Comp Radiopharm; 2014 Mar; 57(3):172-4. PubMed ID: 24470179
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of carbon-14 and stable isotope labeled Avagacestat: a novel gamma secretase inhibitor for the treatment of Alzheimer's disease.
Burrell RC; Easter JA; Cassidy MP; Gillman KW; Olson RE; Bonacorsi SJ
J Labelled Comp Radiopharm; 2014 Aug; 57(10):600-5. PubMed ID: 25196195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
